For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available Detailed specifications, certificates, and supporting documents are available upon request.
(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N Product Information
(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Luciferin. The product is supplied by Clearsynth under CAT No. CS-T-96853.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N is supplied with detailed characterization data compliant with regulatory guideline. (4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Luciferin.
Overview
"(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N is labelled (4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid (K salt, D449725) which is a class of light-emitting heterocyclic compounds found in organisms that cause bioluminescence, such as firefly. It produces light upon oxidative decarboxylation by luciferase in the presence of ATP."
"(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N is labelled (4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid (K salt, D449725) which is a class of light-emitting heterocyclic compounds found in organisms that cause bioluminescence, such as firefly. It produces light upon oxidative decarboxylation by luciferase in the presence of ATP."
Useful product, supplier and regulatory search terms for this reference standard.
Buy high quality (4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15NPurchase (4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N Suppliers(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N Manufacturers(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N PriceOrder (4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15NEnquire (4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N Cost(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N Supplier(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N Distributor(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N for Method Validation(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N for ANDA Filing(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N for Forced Degradation Studies(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N Identification Standards(4S)-4,5-Dihydro-2-(6-hydroxy-2-benzothiazolyl)-4-thiazolecarboxylic Acid-13C2,15N for DMF FilingLuciferin Reference Standard
PATENT DISCLAIMER FOR RESEARCH AND ANALYTICAL USE ONLY
Certain products offered by ClearSynth Labs Limited may be covered by patents or other intellectual property rights in one or more jurisdictions.
Such products are offered exclusively for lawful research, analytical testing, method development, method validation, quality control, and regulatory-related activities, subject to applicable patent laws and exemptions, including, where relevant, 35 U.S.C. 271(e)(1) (United States), Article 10(6) of Directive 2001/83/EC (European Union), Section 60(5)(b) and 60(6D) of the UK Patents Act 1977, and corresponding provisions in other jurisdictions.
These products are not intended for unauthorized commercial pharmaceutical manufacturing, therapeutic administration, or any other use that infringes applicable intellectual property rights.
The purchaser is responsible for ensuring that the purchase, importation, possession, and intended use of the products comply with all applicable patent laws, regulatory requirements, and intellectual property rights.
No patent licence or authorization is granted or implied by the sale of any product. The designation For Research and Analytical Use Only does not itself establish an exemption from patent infringement.
ClearSynth Labs Limited reserves the right to restrict or decline supply where required by applicable laws or regulations.